• 1
    Morinville A, Mayasinger D & Shaver A (1998) From Vanadis to Atropos: vanadium compounds as pharmacological tools in cell death signaling. Trends Physiol Sci 19, 452460.
  • 2
    Εvangelou A (2000) Vanadium in cancer treatment. Crit Rev Oncol Hematol 42, 249265.
  • 3
    Yan S & Wenner CE (2001) Modulation of cyclin D1 and its signaling components by the phorbol ester TPA and the tyrosine phosphatase inhibitor vanadate. J Cell Physiol 186, 338349.
  • 4
    Zhang Z, Huang C, Li J, Leonard SS, Lanciotti R, Butterworth L & Shi X (2001) Vanadate-induced cell growth regulation and the role of reactive oxygen species. Arch Biochem Biophys 392, 311320.
  • 5
    Zhang Z, Leonard SS, Huang C, Vallyathan V, Castranova V & Shi X (2003) Role of reactive oxygen species and MAPKs in vanadate-induced G2/M phase arrest. Free Radic Biol Med 34, 13331342.
  • 6
    Zhang Z, Huang C, Li J & Shi X (2002) Vanadate-induced cell growth arrest is p53-dependent through activation of p21 in C141 cells. J Inorg Biochem 89, 142148.
  • 7
    Ye J, Ding M, Leonard SS, Robinson VA, Millechia L, Zhang Z, Castranona V, Vallyathan V & Shi X (1999) Vanadate induces apoptosis in epidermal JB6P+ cells via hydrogen peroxide-mediated reactions. Mol Cell Biochem 202, 917.
  • 8
    Huang C, Zhang Z, Ding M, Li J, Ye J, Leonard SS, Shen HM, Butterworth L, Lu Y, Costa M et al. (2000) Vanadate induces p53 transactivation through hydrogen peroxide and causes apoptosis. J Biol Chem 275, 3251632522.
  • 9
    Viñals F, McKenzie FR & Pouysségur J (2001) Growth factor-stimulated protein synthesis is inhibited by sodium orthovanadate. Eur J Biochem 268, 23082314.
  • 10
    Huang C, Chen N, Ma WY & Dong Z (1998) Vanadium induces AP-1- and NF-kappaB-dependent transcription activity. Int J Oncol 13, 711715.
  • 11
    Ding M, Li JJ, Leonard SS, Ye JP, Shi X, Colburn NH, Castranona V & Vallyathan V (1999) Vanadate-induced activation of activator protein-1: role of reactive oxygen species. Carcinogenesis 20, 663668.
  • 12
    Aubrecht J, Narla RK, Ghosh P, Stanek J & Uckun FM (1999) Molecular genotoxicity profiles of apoptosis-inducing vanadocene complexes. Toxicol Appl Pharmacol 154, 228235.
  • 13
    Angel P, Szabowski A & Schorpp-Kistner M (2001) Function and regulation of AP-1 subunits in skin physiology and pathology. Oncogene 19, 24132423.
  • 14
    Shaulian E & Karin M (2001) AP-1 in cell proliferation and survival. Oncogene 20, 23902400.
  • 15
    Curran T & Xanthoudakis S (1986) Redox regulation of AP-1: a link between transcription factor signaling and DNA repair. Adv Exp Med Biol 387, 6975.
  • 16
    Angel P & Szabowski A (2002) Function of AP-1 target genes in mesenchymal-epithelial cross-talk in skin. Biochem Pharmacol 64, 949956.
  • 17
    Rosenberg ME & Silkensen J (1995) Clusterin: physiologic and pathophysiologic considerations. Int J Biochem Cell Biol 27, 633645.
  • 18
    Jones SE & Jomary C (2002) Clusterin. Int J Biochem Cell Biol 34, 427431.
  • 19
    Trougakos IP & Gonos ES (2002) Clusterin/apolipoprotein J in human aging and cancer. Int J Biochem Cell Biol 34, 14301448.
  • 20
    Trougakos IP & Gonos ES (2006) Regulation of clusterin/apolipoprotein J, a functional homologue to the small heat shock proteins, by oxidative stress in ageing and age-related diseases. Free Radic Res 40, 13241334.
  • 21
    Shannan B, Seifert M, Boothman DA, Tilgen W & Reichrath J (2006) Clusterin and DNA repair: a new function in cancer for a key player in apoptosis and cell cycle control. J Mol Histol 37, 183188.
  • 22
    Shannan B, Seifert M, Leskov KS, Willis J, Boothman DA, Tilgen W & Reichrath J (2006) Challenge and promise: roles for clusterin in pathogenesis, progression and therapy of cancer. Cell Death Differ 13, 1219.
  • 23
    Hengartner MP (2000) The biochemistry of apoptosis. Nature 407, 770776.
  • 24
    Eliseev RA, Dong Y-F, Sampson E, Zuscik MJ, Schwarz EM, O’Keefe RJ, Rosier RN & Drissi MH (2008) Runx2-mediated activation of the Bax gene increases osteosarcoma cell sensitivity to apoptosis. Oncogene 27, 36053614.
  • 25
    Miyashita T & Reed JC (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80, 293299.
  • 26
    Yang C-R, Yeh S, Leskov K, Odegaard E, Hsu H-L, Chang C, Kinsella TJ, Chen DJ & Boothman DA (1999) Isolation of Ku70-binding proteins (KUBs). Nucleic Acids Res 27, 21652174.
  • 27
    Yang C-R, Lesko K, Hosley-Eberlein K, Criswell T, Pink JJ, Kinsella TJ & Boothman DA (2000) Nuclear clusterin/XIP8, an x-ray-induced Ku70-binding protein that signals cell death. Proc Natl Acad Sci USA 97, 59075912.
  • 28
    Leskov KS, Klokov DY, Li J, Kinsella TJ & Boothman DA (2003) Synthesis and functional analyses of nuclear clusterin, a cell death protein. J Biol Chem 278, 1159011600.
  • 29
    Kolettas E, Skoufos I, Kontargiris E, Markopoulou S, Tzavaras Th & Gonos ES (2006) Bcl-2 but not clusterin/apolipoprotein J protected human diploid fibroblasts and immortalized keratinocytes from ceramide-induced apoptosis: role of p53 in the ceramide response. Arch Biochem Biophys 445, 184195.
  • 30
    Kontargiris E, Kolettas E, Vadalouca AS, Trougakos IP, Gonos ES & Kalfakakou V (2004) Ectopic expression of clusterin/apolipoprotein J or Bcl-2 decreases the sensitivity of HaCaT cells to toxic effects of ropivacaine. Cell Res 14, 415422.
  • 31
    Sherr CJ & Roberts JM (1999) CDK inhibitors: positive and negative regulators of G1 phase progression. Genes Dev 13, 15011512.
  • 32
    Coqueret O (2003) New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment? Trends Cell Biol 13, 6570.
  • 33
    Wang H, Xie Z & Scott RE (1995) Induction of AP-1 activity associated with c-Jun and JunB is required for mitogenesis induced by insulin and vanadate in SV40-transformed 3T3T cells. Mol Cell Biochem 168, 2130.
  • 34
    Yin X, Davison AJ & Tsang SS (1992) Vanadate-induced gene expression in mouse C127 cells: roles of oxygen derived active species. Mol Cell Biochem 115, 8596.
  • 35
    Basset-Séguin N, Escot C, Blanchard JM, Kerai C, Verrier B, Mion H & Guilhou JJ (1990) High levels of c-fos proto-oncogene expression in normal human adult skin. J Invest Dermatol 94, 418422.
  • 36
    Fisher C, Byers MR, Ladarola MJ & Powers EA (1991) Patterns of epithelial expression of Fos protein suggest important role in the transition from viable to cornified cell during keratinization. Development 111, 253258.
  • 37
    Smeyne RJ, Vendrell M, Hayward M, Baker SJ, Miao GG, Schilling K, Robertson LM, Curran T & Morgan JI (1993) Continuous c-fos expression precedes programmed cell death in vivo. Nature 363, 166169.
  • 38
    Bollag WB, Xiong Y, Ducote J & Harmon CS (1994) Regulation of fos–lacZ fusion gene expression in primary mouse epidermal keratinocytes isolated from transgenic mice. Biochem J 300, 263270.
  • 39
    Marti A, Jehn B, Costello E, Keon N, Ke G, Martin F & Jaggi R (1994) Protein kinase A and AP-1 (c-Fos/JunD) are induced during apoptosis of mouse mammary epithelial cells. Oncogene 9, 12131223.
  • 40
    Mils V, Piette J, Barette C, Veyrune J-L, Tesniére A, Escot C, Guilhou J-J & Basset-Séguin N (1997) The proto-oncogene c-fos increases the sensitivity of keratinocytes to apoptosis. Oncogene 14, 15551561.
  • 41
    Mikula M, Gotzmann J, Fischer ANM, Wolschek MF, Thallinger C, Schulte-Hermann R, Beug H & Mikulits W (2003) The proto-oncoprotein c-Fos negatively regulates hepatocellular tumorigenesis. Oncogene 22, 67256738.
  • 42
    Wang Y-H, Chiu W-T, Wang Y-K, Wu C-C, Chen T-L, Teng C-F, Chang W-T, Chang H-C & Tang M-J (2007) Deregulation of AP-1 proteins in collagen gel-induced epithelial cell apoptosis mediated by low substratum rigidity. J Biol Chem 282, 752763.
  • 43
    Criswell T, Klokov D, Beman M, Lavik JP & Boothman DA (2003) Repression of IR-inducible clusterin expression by the p53 tumour suppressor protein. Cancer Biol Ther 2, 372380.
  • 44
    Jin G & Howe PH (1997) Regulation of clusterin gene expression by transforming growth factor β. J Biol Chem 272, 2662026626.
  • 45
    Itahana Y, Piens M, Sumida T, Fong S, Muschler J & Desprez P-Y (2007) Regulation of clusterin expression in mammary epithelial cells. Exp Cell Res 313, 943951.
  • 46
    Reddy KB, Jin G, Karode MC, Harmony JA & Howe PH (1996) Transforming growth factor β (TGFβ)-induced nuclear localisation of apolipoprotein J/clusterin in epithelial cells. Biochemistry 35, 61576163.
  • 47
    Jin G & Howe PH (1999) Transforming growth factor beta regulates clusterin gene expression via modulation of transcription factor c-fos. Eur J Biochem 263, 534542.
  • 48
    Rahimi RA & Leof EB (2007) TGF-beta signaling: a tale of two responses. J Cell Biochem 102, 593608.
  • 49
    Thomas-Tikhonenko A, Viard-Leveugle I, Dews M, Wehrli P, Sevignani C, Yu D, Ricci S, el-Deiry W, Aronow B, Kaya G et al. (2004) Myc-transformed epithelial cells downregulate clusterin, which inhibits their growth in vitro and carcinogenesis in vivo. Cancer Res 64, 31263136.
  • 50
    Scaltriti M, Bettuzzi S, Sharrard RM, Caporali A, Caccamo AE & Maitland NJ (2004) Clusterin overexpression in both malignant and non-malignant prostate epithelial cells induces cell cycle arrest and apoptosis. Br J Cancer 91, 18421850.
  • 51
    Bettuzzi S, Scorcioni F, Astancolle S, Davalli P, Scaltriti M & Corti A (2002) Clusterin (SGP-2) transient overexpression decreases proliferation rate of SV40-immortalized human prostate epithelial cells by slowing down cell cycle progression. Oncogene 21, 43284334.
  • 52
    Petropoulou C, Trougakos I, Kolettas E, Toussaint O & Gonos ES (2001) Clusterin/apolipoprotein J is a novel biomarker of cellular senescence that does not affect the proliferative capacity of human diploid fibroblasts. FEBS Lett 509, 287297.
  • 53
    Schwochau GB, Nath KA & Rosenberg ME (1998) Clusterin protects against oxidative stress in vitro through aggregative and non-aggregative properties. Kidney Int 53, 16471653.
  • 54
    Viard I, Weird P, Jornot L, Bullani R, Vechietti JL, Schifferli JA, Tschopp J & French LE (1999) Clusterin gene expression mediates resistance to apoptotic cell death induced by heat shock and oxidative stress. J Invest Dermatol 112, 290296.
  • 55
    Dumont P, Chainiaux F, Eliaers F, Petropoulou C, Remacle J, Koch-Brandt C, Gonos ES & Toussaint O (2002) Overexpression of apolipoprotein J in human fibroblasts protects against cytotoxicity and premature senescence induced by ethanol and tert-butylhydroperoxide. Cell Stress Chaperones 7, 2335.
  • 56
    Miyake H, Hara I, Gleave ME & Eto H (2004) Protection of androgen-dependent human prostate cancer cells from oxidative stress-induced DNA damage by overexpression of clusterin and its modulation by androgen. Prostate 61, 318323.
  • 57
    Trougakos IP, Lourda M, Agiostratidou G, Kletsas D & Gonos ES (2005) Differential effects of clusterin/apolipoprotein J on cellular growth and survival. Free Radic Biol Med 38, 436449.
  • 58
    Sensibar JA, Sutkowski DM, Raffo A, Buttyan R, Griswold MD, Sylvester SR, Kozlowski JM & Lee C (1995) Prevention of cell death induced by tumour necrosis factor in LNCaP cells by overexpression of sulphated glycoprotein-2 (clusterin). Cancer Res 55, 24312437.
  • 59
    Intich SM, Steinberg J, Kozlowski JM, Lee C, Pruden S, Sayeed S & Sensibar JA (1999) Cytotoxic sensitivity to tumour necrosis factor-alpha in PC3 and LNCaP prostatic cancer cells is regulated by extracellular levels of SGP-2 (clusterin). Prostate 39, 8793.
  • 60
    Miyake H, Nelson H, Rennie PS & Gleave ME (2000) Acquisition of chemoresistance phenotype by overexpression of the anti-apoptotic gene testosterone-repressed prostate message-2 in prostate cancer xenograft models. Cancer Res 60, 25472554.
  • 61
    Trougakos IP, So A, Jansen B, Gleave ME & Gonos ES (2004) Silencing expression of the clusterin/apolipoprotein J gene in human cancer cells using small interfering RNA induces spontaneous apoptosis, reduced growth ability, and cell sensitization to genotoxic and oxidative stress. Cancer Res 64, 18341842.
  • 62
    Sallman DA, Chen X, Zhong B, Gilvary DL, Zhou J, Wie S & Djeu JY (2007) Clusterin mediates TRAIL resistance in prostate tumor cells. Mol Cancer Ther 6, 29382947.
  • 63
    Caccamo AE, Scaltriti M, Caporali A, D’Arca D, Scorcioni F, Astancolle S, Mangiola M & Bettuzzi S (2004) Cell detachment and apoptosis induction of immortalized human prostate epithelial cells are associated with early accumulation of a 45 kDa nuclear isoform of clusterin. Biochem J 382, 157168.
  • 64
    Chen T, Turner J, McCarthy S, Scaltriti M, Bettuzzi S & Yeatman TJ (2004) Clusterin-mediated apoptosis is regulated by adenomatous polyposis coli and is p21 dependent but p53 independent. Cancer Res 64, 74127419.
  • 65
    O’Sullivan J, Whyte L, Drake J & Tenniswood M (2003) Alterations in the post-translational modification and intracellular trafficking of clusterin in MCF-7 cells during apoptosis. Cell Death Differ 10, 914927.
  • 66
    Pajak B & Orzechowski A (2007) Ethylenediaminetetraacetic acid affects subcellular expression of clusterin protein in human colon adenocarcinoma COLO 205 cell line. Anticancer Drugs 18, 5563.
  • 67
    Caccamo AE, Scaltriti M, Caporali A, D’Arca D, Corti A, Corvetta D, Sala A & Bettuzzi S (2005) Ca2+ depletion induces nuclear clusterin, a novel effector of apoptosis in immortalized human prostate cells. Cell Death Differ 12, 101104.
  • 68
    Caccamo AE, Desenzani S, Belloni L, Borghetti AF & Bettuzzi S (2006) Nuclear clusterin accumulation during heat shock response: implications for cell survival and thermo-tolerance induction in immortalized and prostate cancer cells. J Cell Physiol 207, 208219.
  • 69
    Scaltriti M, Santamaria A, Paciucci R & Bettuzzi S (2004) Intracellular clusterin induces G2–M phase arrest and cell death in PC-3 prostate cancer cells. Cancer Res 64, 61746182.
  • 70
    Pucci S, Mazzarelli P, Sesti F, Boothman DA & Spagnoli LG (2009) Interleukin-6 affects cell death escaping mechanisms acting on Bax–Ku70–clusterin interactions in human colon cancer progression. Cell Cycle 8, 473481.
  • 71
    Pajak B & Orzechowski A (2006) Clusterin: the missing link in the calcium-dependent resistance of cancer cells to apoptogenic stimuli. Postepy Hig Med Dosw (Online) 60, 4551.
  • 72
    Batsi C, Markopoulou S, Kontargiris E, Charalambous T, Thomas C, Christoforidis S, Kanavaros P, Constantinou A, Marcu KB & Kolettas E (2009) Bcl-2 blocks 2-methoxyestradiol induced leukemia cell apoptosis by a p27Kip1-dependent G1/S cell cycle arrest in conjunction with NF-κB activation. Biochem Pharmacol 78, 3344.
  • 73
    Li X, Massa PE, Hanidu A, Peet GW, Aro P, Savitt A, Mische S, Li J & Marcu KB (2002) IKKα, IKKβ, and NEMO/IKKγ are each required for the NF-κB-mediated inflammatory response program. J Biol Chem 277, 4512945140.
  • 74
    Santilli G, Aronow BJ & Sala A (2003) Essential requirement of apolipoprotein J (clusterin) signaling for IκB expression and regulation of NF-κB activity. J Biol Chem 278, 3821438219.
  • 75
    Devauchelle V, Essabbani A, De Pinieux G, Germain S, Tourneur L, Mistou S, Margottin-Goguet F, Anract P, Migaud H, Le Nen D et al. (2006) Characterization and functional consequences of underexpression of clusterin in rheumatoid arthritis. J Immunol 177, 64716479.
  • 76
    Takase O, Marumo T, Hishikawa K, Fujita T, Quigg RJ & Hayashi M (2008) NF-κB-dependent genes induced by proteinuria and identified using DNA microarrays. Clin Exp Nephrol 12, 181188.
  • 77
    Perkins ND (2007) Integrating cell signalling pathways with NF-κB and IKK function. Nat Rev Mol Cell Biol 8, 4962.
  • 78
    Pucci P, Bonanno E, Pichiorri F, Angeloni C & Spagnoli LG (2004) Modulation of different clusterin isoforms in human colon tumorigenesis. Oncogene 23, 22982304.
  • 79
    Roux P, Blanchard JM, Fernandez A, Lamb N, Jeanteur P & Piechaczyk M (1990) Nuclear localization of c-Fos, but not v-Fos proteins, is controlled by extracellular signals. Cell 63, 341351.
  • 80
    Dimri GP & Campisi J (1994) Altered profile of transcription factor-binding activities in senescent human fibroblasts. Exp Cell Res 212, 132140.
  • 81
    Kolettas E, Buluwela L, Bayliss MT & Muir HI (1995) Expression of cartilage-specific molecules remains unaffected by long-term culture of human articular chondrocytes. J Cell Sci 108, 19911999.
  • 82
    Kolettas E, Evangelou A & Gonos ES (2001) v-FBR-fos oncogene fails to rescue mammalian cells from growth arrest but affects the responses of human fibroblasts to heparin. Anticancer Res 21, 435444.